We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Cross-linked Hydrogels Developed for 3D Printing

By LabMedica International staff writers
Posted on 08 Jan 2018
A team of Japanese biomedical engineers has developed a novel, enzyme-based three-dimensional printing method that enables in vitro growth of complex cellular structures.

Investigators at Osaka University (Japan) reported in the December 11, 2017, online edition of the journal Macromolecular Rapid Communications that they had developed a cytocompatible inkjet bio-printing approach that enabled the use of a variety of bio-inks to produce hydrogels with a wide range of characteristics.

Stabilization of bio-inks was obtained by using the enzyme horseradish peroxidase (HRP) to catalyze cross-linking within the hydrogel while consuming cytotoxic hydrogen peroxide (H2O2) in the process.

Three-dimensional cell-laden hydrogels were fabricated by the sequential dropping of a polymer-containing bio-ink that had been cross-linked through the enzymatic reaction and H2O2 onto droplets of another bio-ink that contained the polymer, HRP, and cells. More...
The HRP in the second drop neutralized the H2O2 carried over in the first drop. This approach promoted adhesion of the biological ink droplets and allowed printing of complex biological structures. The approximately 95% viability of mouse fibroblasts enclosed in a bio-ink hydrogel consisting of gelatin and hyaluronic acid derivatives and subsequent elongation of the cells demonstrated the suitability of this three-dimensional printing approach.

"Advances in induced pluripotent stem cell technologies have made it possible for us to induce stem cells to differentiate in many different ways," said senior author Dr. Makoto Nakamura, professor of biochemical engineering at Osaka University. "Now we need new scaffolds so we can print and support these cells to move closer to achieving full three-dimensional printing of functional tissues. Our new approach is highly versatile and should help all groups working to this goal."

Related Links:
Osaka University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
All-in-One Molecular System
AIO M160
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.